Purchase Order 75F40126P00019
Award Date 5/5/26
Potential Completion Date 5/4/27
Potential Value $25K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp. a $21,810 purchase order to provide helium fill maintenance services for a 600 MHz nuclear magnetic resonance spectrometer located in Billerica, Massachusetts. As the prime contractor, Bruker Biospin will perform the requested maintenance through December 2024 on the equipment, which is used to support the FDA's regulatory and research efforts. No subcontractors or set aside designations were...
- This is a purchase order awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for an annual helium fill service for a 600 MHz nuclear magnetic resonance (NMR) spectrometer. The contract has a firm fixed price of $24,320.00 and a completion date of March 9, 2026. Bruker Biospin Corp is a subsidiary of Bruker Scientific LLC, which has a history of providing specialized analytical equipment and maintenance services to various federal...
- The Food and Drug Administration awarded a $25,850 purchase order to Bruker Biospin Corp on August 11, 2022, for the procurement of cryogenic liquids required to support nuclear magnetic resonance (NMR) spectrometer installation and operations at the FDA's facility in Silver Spring, Maryland. The contract was structured as a firm fixed-price purchase order with an ultimate completion date of August 10, 2023, and did not utilize any small business set-aside designation. Cryogenic liquids,...
- The U.S. Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp for a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer on September 29, 2021. The contract, which was completed by September 28, 2022, fulfills the FDA's Center for Drug Evaluation and Research requirement for high-resolution analytical equipment to characterize pharmaceutical ingredients, drug products, and excipients for stability and quality assessment in both liquid and...
- <p>The Food and Drug Administration awarded a purchase order to Bruker Biospin Corp for an NMR CONSOLE AVANCE NEO 500 MHz with a ceiling value of $732,711.84 on September 18, 2022, with ultimate completion on September 17, 2023. Performance occurs in Billerica, Massachusetts. The order covers procurement of a single advanced nuclear magnetic resonance spectrometer system on a firm fixed price basis with no set-aside designation.</p>
- The U.S. Food and Drug Administration (FDA) awarded a $195,933.11 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, to acquire a comprehensive service agreement from the original equipment manufacturer (OEM) Bruker. The agreement includes preventive maintenance with two (2) helium refills per year, as well as any repairs and support for a Bruker Avance III HD 600 instrument. The award has an ultimate completion date of August 31, 2027. Bruker...
- The U.S. Food and Drug Administration (FDA) awarded a $36,020 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for preventive maintenance and repair services for the cryo-cooler components of a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit located at the National Center for Toxicological Research (NCTR) in Jefferson, AR. The contract includes one scheduled on-site preventive maintenance service per year, unlimited on-site corrective...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Biomedical Imaging and Bioengineering, a civilian agency, to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of liquid helium refill services for ongoing laboratory research. The contract has a ceiling value of $21,090.00 and an ultimate completion date of March 31, 2026. There was no set-aside designation used for this contract. Bruker Biospin Corp is a manufacturer of...
- This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
- <p>The Office of Naval Research awarded a purchase order to Bruker Biospin Corp valued at $8,054.60 on March 31, 2026, for bi-annual liquid helium refills on an NMR instrument. Performance occurs in Washington, DC 20375. The order carries a firm fixed price and concludes on May 31, 2027.</p>
The Food and Drug Administration awarded a purchase order to Bruker Biospin Corp on May 5, 2026, for annual liquid helium fill service for a 600 MHz NMR spectrometer, with a ceiling value of $25,010.00. Performance occurs in St. Louis, Missouri at the Center for Drug Evaluation and Research, Office of Pharmaceutical Quality Research. The order is firm fixed price with an ultimate completion date of May 4, 2027.
Generated 7/2/26, 3:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 5/6/26 |